Skip to main content

mRECIST objective response and early tumor shrinkage predict survival in sorafenib-treated HCC

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
mRECIST objective response and early tumor shrinkage predict survival in sorafenib-treated HCC

User login

Username

Password

Reset your password

Type	Lead	score